In the fourth quarter of 2024, three Biologics companies received three FDA inspections in South Carolina, according to the U.S. Food and Drug Administration (FDA).
This was the lowest number of inspections per type of company made by the FDA in South Carolina, equalling 37.5% of all inspections in the fourth quarter of 2024.
Of all the South Carolina companies involved in the Biologics sector, Lexington Medical Center received the most citations from the FDA in the fourth quarter of 2024.
The FDA routinely inspects facilities across the nation to determine if the workplace and their products are compliant with FDA-regulated laws and regulations implemented to improve overall public health. Inspection results are then disclosed publicly.
According to its website, the FDA is a government agency that is primarily responsible for monitoring the production and distribution of human and animal drugs, biological products, medical supplies and tobacco products for safety quality.
| Project Area | No Action Indicated | Voluntary Action Indicated | Official Action Indicated |
|---|---|---|---|
| Blood and Blood Products | 2 | 1 | — |
| Food Composition, Standards, Labeling and Econ | 2 | — | — |
| Foodborne Biological Hazards | 2 | 3 | — |
